Bioxyne Limited (AU:BXN) has released an update.
Bioxyne Limited has announced that over 1.2 billion of its shares will be released from escrow on May 19, 2024, with major shareholders voluntarily extending their escrow on 1 billion shares for an additional year, signaling their confidence in the company’s anticipated rapid growth. The company, which operates internationally in the health and pharmaceutical sector, boasts a diverse portfolio that includes health and wellness products, psychotropic substances, and investigational medicines, with a significant presence in Australia, the UK, Europe, and Japan.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.
